US ▾
ALMU
Earnings call · Jun 2026 (Q4 FY26)

Aeluma Q4 FY26 earnings call ALMU

Sep 16, 2026 Source

Executive summary

Aeluma Q4 FY26 — Accelerating AI DataCom Commercialization with Strategic Partnerships and CHIPS Funding

Aeluma concluded Q4 FY26 by establishing a strong foundation for commercialization, particularly in the AI DataCom market, driven by its non-indium phosphide photonics platform. The company secured significant CHIPS R&D funding and strengthened strategic manufacturing partnerships to scale production. While operating expenses increased due to talent investments, leading to wider losses, management is confident in its disciplined approach to capitalize on the growing demand for high-performance photonics.

Highlights

5

  • Secured a letter of intent for up to $30 million in CHIPS R&D funding to accelerate development and commercialization.

  • Closed Q4 FY26 with a strong balance sheet, including $56 million in cash and cash equivalents, up from $37.8 million in Q3 FY26.

  • Executed an agreement with Sumitomo Chemical Advanced Technologies to increase wafer production capacity for high-speed photodetectors.

  • Expanded team from 14 to over 30 employees, including key hires like VP of Engineering and Senior Director of Program Management.

  • Fiscal 2026 revenue of $4.5 million was near the high end of the previously provided range.

Concerns

3

  • GAAP net loss for Q4 FY26 was $4 million ($0.22 per share), and for FY26 was $9.2 million ($0.52 per share), significantly wider than FY25.

  • Adjusted EBITDA for FY26 was negative $5.2 million, compared to positive $186,000 in FY25, driven by increased operating expenses.

  • Fiscal 2027 government contract revenue is expected to be approximately $2.3 million, a decrease from FY26's $4.5 million, due to a shift towards commercialization.

Guidance & targets

CategoryTargetConfidence
Government contract revenue
$2.3 million
medium materiality
High
Capital expenditures
$10 to $12 million
medium materiality
High

Product announcements

ProductTypeDetails
LINX S-Series photodetectorsroadmap
LINX F-Series photodetectorsroadmap
Quasar family of quantum dot lasersroadmap

Deals & partnerships

Sumitomo Chemical Advanced Technologies Agreement to strengthen relationship and increase wafer production capacity.

The agreement will support commercialization efforts and complement Aeluma's in-house capability, focusing on high-speed photodetectors for AI DataCom. It leverages existing MOCVD tools and provides a path for further increasing capacity.

Capital programs

CHIPS R&D Office Funding under definitive agreement negotiations up to $30 million
Funding: U.S. government equity investment

Benefit:accelerate development and commercialization of our scalable photonics for AI and advanced computing

On July 29, we announced a letter of intent with the Department of Commerce, CHIPS R&D Office, for up to $30 million to accelerate development and commercialization of our scalable photonics for AI and advanced computing. ... While the terms are not yet final, our current understanding is that if finalized, this award is likely to be accounted for as an equity investment in Aeluma by the U.S. government and not as revenue of our previous government R&D contracts.

MOCVD Reactor Procurement and Installation procuring multiple AIXTRON G10 MOCVD systems; planning for installation
Period spend: $10 to $12 million

Benefit:expand epitaxy wafer production capacity; ramp proprietary process with supply chain partners

With respect to manufacturing, we are focused on expanding epitaxy wafer production capacity, Sumitomo Chemical Advanced Technologies, qualifying our processes with additional supply chain partners, and expanding our capabilities through the purchase of the latest generation of MOCVD reactors, test and validation tools. As such, we expect to make meaningful investments in fiscal 2027, anticipating capital expenditures of approximately $10 to $12 million.

Risks & headwinds

Shift from government contract revenue to commercialization Fiscal 2027

FY27 expected government revenue $2.3 million vs FY26 $4.5 million

Mitigation:Focus on commercial NRE agreements and CHIPS funding to accelerate commercialization and generate long-term shareholder value.

Increased operating expenses leading to wider losses Fiscal 2026

FY26 Adjusted EBITDA negative $5.2 million vs FY25 positive $186,000

Mitigation:Making prudent investments in talent, systems, and processes to scale the business, while maintaining a strong balance sheet and disciplined operations.

Indium phosphide substrate bottleneck in the industry Ongoing

Not directly quantified, but stated as a significant industry bottleneck impacting supply and scalability.

Mitigation:Aeluma's proprietary non-indium phosphide platform (gallium arsenide, silicon) and MOCVD technology offer a scalable alternative, overcoming supply chain constraints.

What to watch in Q1 FY27

CHIPS R&D funding finalization

next quarter
Current Letter of intent for up to $30 million, definitive agreement negotiations underway.
Target Finalized agreement, accounting treatment confirmed (equity investment).

Why it matters

This funding is crucial for accelerating Aeluma's commercialization efforts in AI DataCom and provides significant capital.

We are continuing to work through diligence and drafting of the definitive agreements related to our letter of intent with the Department of Commerce, CHIPS R&D Office, for up to $30 million in funding.

Q&A highlights

Does the delayed government program revenue from FY26 carry over to FY27?

Chris Stewart stated that Aeluma is not providing official guidance for FY27 due to variability from contracts. Booked government contract revenue for FY27 is $2.3 million, with potential for an additional $2 million.

“Well, the revenue, as we talked about in the first remarks, we are not providing official guidance this year, mainly because there is a handful of contracts that could really change the range quite a bit. We continue to deliver on the projects that we signed last year, and there are some programs that are continuing on from prior years. As we said, that book revenue, including the new contracts that we signed this year, is about $2.3 million. And then clearly there is a number of things that could bring upside from there, but at this point, you know, we are prepared to give more visibility than that.”

asked by Daniel Yermackin · answered by Christopher Stewart

2 min read 6 chapters

Detailed narrative

AI DataCom Market Opportunity

Aeluma is prioritizing the AI DataCom market, with data center CapEx expected to reach $1.8 trillion by 2030, 10-15% of which is for photonics. The company's proprietary heterogeneous integration platform, using large diameter non-indium phosphide substrates, is designed to address this scale and overcome supply chain bottlenecks. Forecasts for this market continue to increase, driving urgency for Aeluma's solutions.

Technology & Product Focus

The company is accelerating development and commercialization of LINX S-Series (slow and wide, up to 64 Gbps) and F-Series (fast and narrow, 200-400 Gbps per lane) photodetectors, and Quasar quantum dot lasers. These technologies eliminate reliance on indium phosphide, support high-volume manufacturing, and offer a path to CMOS wafer-scale integration. Both photodetectors and lasers are considered equally significant opportunities.

Strategic Partnerships & Scaling

Aeluma executed an agreement with Sumitomo Chemical Advanced Technologies to strengthen its relationship and increase wafer production capacity, leveraging existing MOCVD tools. The company is also procuring multiple AIXTRON G10 MOCVD systems for installation. These efforts aim to utilize larger diameter substrates (150mm gallium arsenide, future silicon) to scale production and meet demand, complementing Aeluma's in-house capabilities.

Government Funding & Commercialization Shift

While historically relying on non-dilutive government R&D contracts, Aeluma is shifting its focus to commercialization. It secured a letter of intent for up to $30 million from the Department of Commerce CHIPS R&D Office, which is expected to be accounted for as an equity investment rather than revenue. This funding is intended to accelerate AI product development and commercialization efforts.

Team Expansion & Operational Foundation

Aeluma expanded its team from 14 employees at June 30, 2025, to over 30 employees as of the call date, with plans for further recruitment. Key hires include Dr. Brendan Moran as VP of Engineering and Jason Taylor as Senior Director of Program and Project Management. Dr. Pramit Parikh also joined as a strategic advisor. These investments are building the organizational foundation required to execute the company's strategy and scale the business.

Financial Position & Capital Discipline

The company ended Q4 FY26 with a strong balance sheet, including $56 million in cash and cash equivalents and no debt. This position was bolstered by $20.1 million in net proceeds from its ATM facility. Management emphasizes maintaining a strong balance sheet to execute its growth strategy and reinforce credibility with customers, while remaining committed to disciplined operations despite increased operating expenses.

AI-generated summary of the company's earnings call. Not investment advice.